0.6181

0.66% -0.0041

Beyondspring Inc (BYSI)

Overview News Price History Option Chain Discussions Forecast

Beyondspring Inc stock is traded at $0.6181, with a volume of 26,729. It is down -0.66% in the last 24 hours and down -37.57% over the past month. BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.

Previous Close:

$0.6222

Open:

$0.628

24h Volume:

26,729

Relative Volume:

0.04

Market Cap:

$25.42M

Revenue:

$1.88M

Net Income/Loss:

$-8.48M

P/E Ratio:

-3.286

EPS:

-0.1881

Net Cash Flow:

$-19.13M

1W Performance:

-7.11%

1M Performance:

-37.57%

6M Performance:

-59.86%

1Y Performance:

-66.41%

1-Day Range:

$0.60

$0.6477

1-Week Range:

$0.60

$0.6625

52-Week Range:

$0.5657

$2.44

Beyondspring Inc Stock (BYSI) Company Profile

Name

Beyondspring Inc

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

646-528-4184

Address

100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR, FLORHAM PARK, NY

Employee

Twitter

@BeyondSpringInc

Next Earnings Date

2026-08-12

Latest SEC Filings

BYSI's Discussions on Twitter

Compare BYSI vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BYSI Beyondspring Inc	0.6181	29.61M	1.88M	-8.48M	-19.13M	-0.1881
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Beyondspring Inc Stock (BYSI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-02-21	Downgrade	BofA Securities	Buy → Underperform
Dec-02-21	Downgrade	Jefferies	Buy → Hold
Dec-01-21	Downgrade	H.C. Wainwright	Buy → Neutral
Dec-01-21	Downgrade	William Blair	Outperform → Mkt Perform
Sep-09-21	Initiated	Robert W. Baird	Outperform
Aug-04-21	Upgrade	H.C. Wainwright	Neutral → Buy
Apr-05-21	Downgrade	H.C. Wainwright	Buy → Neutral
Jan-11-21	Initiated	BofA Securities	Buy
Dec-29-20	Initiated	Evercore ISI	Outperform
Feb-07-20	Initiated	Jefferies	Buy
Jan-10-20	Initiated	Nomura	Buy
Dec-03-19	Initiated	William Blair	Outperform
Jul-10-19	Reiterated	H.C. Wainwright	Buy
Apr-30-19	Downgrade	Maxim Group	Buy → Hold
Oct-25-18	Reiterated	Maxim Group	Buy

View All

Beyondspring Inc Stock (BYSI) Latest News

Aug 21, 2026

BeyondSpring (BYSI) Results Versus Estimates: Available Data Shows the Latest Reported Performance in Latest Trading; Market Reaction: Shares Close 0.28% Lower in the Current UpdatePositive Surprise Momentum - vinanet.vn

Aug 21, 2026

Aug 19, 2026

BeyondSpring (BYSI) Range: Adds 4.89% to Close at $0.75 in the Current Update; Market Levels: the Supplied Trading Band Runs From $0.71 to $0.79 in the Latest SessionSMA Signal - vinanet.vn

Aug 19, 2026